Abstract. Discussion of risk factors for infectious complications in the general population of patients undergoing transurethral resection of the prostate, antibiotic prophylaxis and therapy has been going on for decades. Up to date, the problem of the manifestation of bacteriuria in clinical infectious processes at various periods, as well as the factors of the introduction of bacterial agents with their further subclinical circulation in the urinary and reproductive systems, seems to be little discussed. The insufficient knowledge of these issues is confirmed by a small number of studies covering mainly electrosurgical mono and bipolar technologies as the most common and studied over a long period of their existence. This review raises the problem of insufficient knowledge of the clinical structure of infections during transurethral surgery, assessment of their risk factors, antibiotic prophylaxis regimens and therapy.
References:
1. Grabe M. Antimicrobial agents in transurethral prostatic resection. J Urol. 1987;138(2):245-52. DOI: 10.1016/s0022- 5347(17)43109-0.
2. Wagenlehner FM, Wagenlehner C, Schinzel S, Naber KG. Prospective, randomized, multicentric, open, comparative study on the efficacy of a prophylactic single dose of 500 mg levofloxacin versus 1920 mg trimethoprim/ sulfamethoxazole versus a control group in patients undergoing TUR of the prostate. Eur Urol. 2005;47(4):549-56. DOI: 10.1016/j.eururo.2005.01.004.
3. Girou E, Rioux C, Brun-Buisson C, Lobel B. Infection Committee of the French Association of Urology. The postoperative bacteriuria score: a new way to predict nosocomial infection after prostate surgery. Infect Control Hosp Epidemiol. 2006;27(8):847-54. DOI: 10.1086/506398.
4. Osman T, ElSaeed KO, Youssef HA, Shabayek M, Emam A, Hussein MS. Evaluation of the risk factors associated with the development of post-transurethral resection of the prostate persistent bacteriuria. Arab J Urol. 2017;15(3):260- 6. DOI: 10.1016/j.aju.2017.05.004.
5. Colau A, Lucet JC, Rufat P, Botto H, Benoit G, Jardin A. Incidence and risk factors of bacteriuria after transurethral resection of the prostate. Eur Urol. 2001;39(3):272-6. DOI: 10.1159/000052452.
6. Huang X, Shi HB, Wang XH, Zhang XJ, Chen B, Men XW, Yu ZY. Bacteriuria after bipolar transurethral resection of the prostate: risk factors and correlation with leukocyturia. Urology. 2011;77(5):1183-7. DOI: 10.1016/j.urology.2010.08.013.
7. Evan Botti F, Oleszak M, Likhtshteyn A, Maryniak M. Rahman Infective Endocarditis Following TURP Procedures: A Case Report and Review of Literature. American Journal of Medical Case Reports. 2020;8(10):370-3. DOI: 10.12691/ ajmcr-8-10-14.
8. Schneidewind L, Kranz J, Schlager D. Mulitcenter study on antibiotic prophylaxis, infectious complications and risk assessment in TUR-P. Cent European J Urol. 2017;70(1):112- 7. DOI: 10.5173/ceju.2017.941.
9. El Basri A, Petrolekas A, Cariou G, Doublet JD, Hoznek A, Bruyere F. Clinical Significance of Routine Urinary Bacterial Culture After Transurethral Surgery: Results of a Prospective Multicenter Study. Urology. 2011;79(3):564-9. DOI: 10.1016/j.urology.2011.11.018.
10. Guo RQ, Yu W, Meng Y. Correlation of benign prostatic obstruction-related complications with clinical outcomes in patients after transurethral resection of the prostate. The Kaohsiung Journal of Medical Sciences. 2017;33(3):144-151. DOI: 10.1016/j.kjms.2017.01.002.